Clinical trial to study the effect of Ushira choorna compared with Rabeprazole in the management of Gastritis and Duodenitis

A randomized open label controlled clinical trial to evaluate the efficacy of Ushira choorna (Vetiveria zizanioides) compared with Rabeprazole in the management of Gastritis and Duodenitis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107291

Enrollment

Registered

2026-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K299- Gastroduodenitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Signs and symptoms of Acid Peptic Disease, having OGD scopy evidence of Gastric or Duodenal Ulcer, patients willing for endoscopy

Exclusion criteria

Exclusion criteria: Patients having Malignancy, H Pylorie, HIV, HBsAg infection, Hiatus Hernia, Tuberculosis, Stricture, Varices, Forrest Classification 1a,1b,2a,2b

Design outcomes

Primary

Measure	Time frame
Is Ushira Choorna effective in the management of Gastritis and DuodenitisTimepoint: 3 weeks	—

Secondary

Measure	Time frame
1) Evaluate clinical improvement in signs and symptoms of Acid Peptic Disease with the administration of Ushira Choorna and RabeprazoleTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Naimish Saraf

Shree Guru Gobind Singh Tricentenary University, Faculty of Indian Medical System

avnish_fims@sgtuniversity.org9886593705

Outcome results